Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools
MT newswire2026/10/06 13:2909:29 AM EDT, 10/06/2026 (MT Newswires) -- Cognizant Technology Solutions (CTSH) said Tuesday that it has signed a five-year extension agreement with Gilead Sciences (GILD) to support DevOps capabilities and the use of agentic artificial intelligence tools for certain technology programs. Cognizant said the updated scope will focus on uses intended to simplify processes, improve delivery, and help Gilead conduct priority technology programs more efficiently. Shares of Cognizant and Gilead were up 1.9% and 0.2% respectively in premarket activity Tuesday.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
JPMorgan raises AbbVie target price to $300